Maria Tomaro
Nurse Practitioner · Cleveland, OHNPI 1477936870
Payments from drug & device makers
Across 23 payments — averaging $33.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$250
- Seagen Inc.$95
- Intera Oncology, Inc$51
- Novartis$48
- Merck$43
- Regeneron Healthcare Solutions, Inc.$35
- plus $248 from 12 others
What the payments were for
- Food & beverage$67488%
- Education$9512%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 4 | $250 |
| Seagen Inc. | 1 | $95 |
| Intera Oncology, Inc | 1 | $51 |
| Novartis | 2 | $48 |
| Merck | 2 | $43 |
| Regeneron Healthcare Solutions, Inc. | 1 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| Exelixis Inc. | 1 | $27 |
| Astellas Pharma US Inc | 1 | $27 |
| Sobi, Inc | 1 | $25 |
| Stemline Therapeutics Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $21 |
| Gilead | 1 | $18 |
| Caris MPI, Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $16 |
| Genentech USA, Inc. | 1 | $15 |
| Pfizer | 1 | $14 |
| Array Biopharma Inc | 1 | $13 |
How this compares
$769 in reported general payments places this provider in the 80th percentile of 4,700 nurse practitioner providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Imatinib Mesylate | 14 | $57,899 |
| Potassium Chloride | 59 | $624 |
| Ondansetron Hcl | 33 | $533 |
| LoperamideLoperamide Hcl | 16 | $464 |
| Nystatin | 25 | $422 |
| Gabapentin | 35 | $318 |
| Omeprazole | 15 | $228 |
| Prochlorperazine Maleate | 17 | $181 |
| Pantoprazole Sodium | 17 | $158 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 13 | $152 |
| Furosemide | 16 | $23 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Cleveland
- Margaret BobonichCleveland$235K
- Beth FaimanCleveland$101K
- Jessica GlennieCleveland$40K
- Elizabeth KirchnerCleveland$27K
- Desiree ChizmadiaCleveland$15K
- Julie WidmarCleveland$12K
- Suzanne FortunaCleveland$9K
- Mary GallagherWestlake$229K
- Sonia HissettCincinnati$179K
- Ashley TaylorNew Albany$107K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.